Susan Hasty, Publisher
Table of Contents . . . July 22nd, 2004
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in FDA Law Weekly | Other Publications
Advanced Magnetics, Inc. - Response submitted to FDA approvable letter for Combidex
Alzheimer Disease - Alzheimer Association seeks annual $1B federal investment for research
American Pharmaceutical Partners, Inc. - FDA grants approval for dimenhydrinate injection
Amgen, Inc. - Biologics License Application submitted for FDA approval of Palifermin
Andrx Corporation - FDA issues approvable letter for Cardura XL; OKs antibiotic ANDA
Barrier Therapeutics, Inc. - Liarozole receives FDA orphan drug status
Bayer HealthCare, LLC - FDA grants clearance for two additional claims for BNP test
Baystate Medical Center - Transdermal contraceptive system reviewed
Biological Threat - Art professor indicted over biological materials
Bioterrorism - New reporting requirement to help fight bioterrorism
Biovail Corporation - Glumetza NDA accepted by FDA
Cancer Therapy - NCI selects SRI to qualify cancer drug candidates for clinical studies
Cardima - Device company meets with FDA regarding Revelation Tx
Cardiome Pharma Corp. - Cardiome receives FDA approvable letter on oxypurinol for gout
Celltech Group plc - U.S. FDA approves 12-hour Codeprex
Aarhus University - TARTAR dimer therapeutic target for treatment of HIV-1 infection
Ajou University - Genistein may be an alternative to estrogen for treatment of AD
Amrad - Australian anti-infectives business to be demerged
Arthritis - RehabCare Group develops strategic partnership with Arthritis Foundation
Assn for Professionals in Infection Control & Epid - Organization advocates improving worker influenza immunization rates
Auxeris Therapeutics Inc. - Biopharmaceutical company names new chief scientific officer
Awards - PacifiCare receives National Exemplary Practice Award for diabetes program
Bayer - Extended-release ciprofloxacin effectively treats UTI and combats resistance
Baylor College of Medicine - Breast tumor cell destruction by herpesvirus induces antitumor immunity
CHF Solutions, Inc. - Device maker appoints Paul A. Sobotka chief medical officer
Cancer Mortality - CDC: More people with cancer surviving
Cancer Treatment - Ocala Oncology inks agreement with Shands HealthCare, UF Health Science Center
Cardiovascular Disease - Women with diabetes face higher risk of artery disease from hormones
Case Western Reserve University - Implanted doxorubicin localizes at healing tissues in ablated rat livers
CeMines, Inc. - Diagnostics company expands, relocates
Charite-Univ. of Medicine Berlin - Fibrin-sealant matrices containing taurolidine blanket brain tissues
Chiron Corporation - Nonexclusive HCV license granted to Prosetta
Cumberland - Acetadote launched for aspirin overdose
CuraGen Corporation - Preclinical data presented on CG53135
Dana Farber Cancer Inst., Boston - EGFR mutations in lung cancer may predict sensitivity to gefitinib therapy
Defibtech - FDA grants clearance to market pediatric defibrillation pads
Dendrite International, Inc. - Company to provide clinical trial support services
Durect Corporation - Agreement signed to develop treatments for inner ear disorders
Dynavax Technologies Corporation - Phase II/III hepatitis B trial initiated
GATA Haydarpasa Military Hospital, Istanbul - Hyperbaric oxygen therapy relieves pain of syndrome
Gloucester Pharmaceuticals, Inc. - Encouraging results from NCI-sponsored study with FK228 in T-cell lymphomas
HIV/AIDS Treatment - Combination therapy reduces mother-to-child transmission rate to below 2%
HIV/AIDS Treatment - Study shows multivitamins slowed down AIDS virus in African women
HKU Pasteur Research Center, Hong Kong - SARS-CoV proteinase inhibitors may be developed from existing drugs
Hamamatsu University - Glycyrrhetinic acid exerts differential effects in obese and lean rats
Healthcare Coverage - Plenaxis assigned Medicare permanent billing code for hospital use
Hebrew University of Jerusalem - Method for direct treatment of intestinal illnesses wins prize
Hoffmann-La Roche - New Drug Application submitted to FDA for Invirase 500-mg tablet formulation
Hospital General Univ. Gregorio Maranon, Madrid - HAART effects survival and surrogate markers in vertically HIV-infected children
INFOGEN, Berlin - The Rosuvastatin GALAXY Program studies cardiovascular risk reduction
Innsbruck University - Interleukin-6 stimulates VEGF autocrine loops in prostate cancer cells
Inst. of Clinical & Experimental Medicine, Prague - Left ventricular is preferred over biventricular pacing in chronic heart failure
Janssen Pharmaceutica Products, L.P. - FDA applies Duragesic 6-month period of pediatric exclusivity
Jinan University - Chitosan-plasmid DNA nanoparticles used for contraceptive vaccine
John F. Kennedy Inst., Glostrup - Cutaneous gene transfer widens options for systemic gene delivery
Planar Systems, Inc. - FDA approves marketing of flat-panel DomeC5i system for mammograms
Prescription Fraud - Nebraska state senator arrested, accused of prescription fraud
Ranbaxy Pharmaceuticals Inc. - Pharmaceutical company receives approval to market metformin hydrochloride
Teva Pharmaceutical Industries Ltd. - Israel-based pharmaceutical company receives FDA approval for Metformin HCl
Thermage, Inc. - FDA clears ThermaCool device for treatment of facial wrinkles and rhytids
U.S. Centers for Medicare & Medicaid Svcs. - Medicare boosts payments for ambulance transportation
U.S. Food & Drug Administration - Infrared methodologies for trans fat determination reviewed
U.S. Food & Drug Administration - Silver-ion HPLC improves identification of linoleic acid isomers
U.S. Naval Medical Research Center, Silver Spring - Rickettsia prowazekii Madrid E strain proteome analyzed
U.S. Smithsonian Environmental Research Center - West Nile virus control dependent on animal monitoring and disease research
Univ. of Medicine & Dentistry, New Jersey - Vacuum-assisted deliveries are safe alternative to forceps
West Nile Virus - Two more West Nile cases reported in New Mexico
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.